Tatsuya Suzuki

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa et al. · Cell · 2021 · 290 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2

Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori et al. · Nature Communications · 2021 · 146 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response

Shunya Tsuji, Shohei Minami, Rina Hashimoto et al. · Nature Aging · 2022 · 91 citations · Full text

Veterinary Medicine, Cell Biology, Infectious Diseases +17

Effective Production of Levulinic Acid from Biomass through Pretreatment Using Phosphoric Acid, Hydrochloric Acid, or Ionic Liquid

Yosuke Muranaka, Tatsuya Suzuki, Hiroyuki Sawanishi et al. · Industrial & Engineering Chemistry Research · 2014 · 68 citations

Life Sciences, Biochemistry, Biotechnology +14

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo

Nariko Ikemura, Shunta Taminishi, Tohru Inaba et al. · Science Translational Medicine · 2022 · 65 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17